Article
Rare mutations provide unique insight into oncogenic potential of STAT transcription factors.
The Journal of clinical investigation - 2 Jan 2018
Heppler Lisa N, Frank David A
Abstract excerpt
The inappropriate activation of transcription factors, including STATs, is known to promote tumor initiation and progression. The most common mechanisms of misregulation lead to constitutive activation of WT STATs. However, the recent discovery of rare STAT mutations in hematopoietic malignancies suggests that STAT mutants may be oncogenic. In this issue of the JCI, Pham et al. use a transgenic mouse model to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
